Share this via
L'Oreal is set to acquire a majority stake in Medik8, a British skincare brand known for its vitamin A-focused products. This strategic move aims to bolster L'Oreal's presence in the thriving skincare market. The deal, valuing Medik8 at approximately €1 billion, will see Inflexion, the current majority holder, retain a minority share.
While Felix Pharmaceuticals achieved its first U.S. FDA approval in 2020, it has quickly scaled to a 14 commercialised product portfolio and has several others in advanced stages of pipeline.
Top US and Chinese officials convened in London to de-escalate trade tensions that have destabilized global markets. Discussions, led by key figures like He Lifeng and Howard Lutnick, follow a temporary truce established in Geneva. Disa ...more
During 2024-25, the bank earned a record net profit of ₹70,901 crore, as against ₹61,077 crore in the preceding year, registering a 16 increase
Get over your FOMO of knowing what's happening. Never miss what matters to you!
